The quote that you used in your post was from a 2/24/20 PR. There have been 9 additional IPIX PRs regarding advancement of Brilacidin for COVID-19 since that time. Each PR builds on the previous PR as the science continues to be tested and discussions for partnerships, grants and collaborations advance.

From 2/24/PR
“The Company has submitted a preliminary summary of Brilacidin’s potential as a novel coronavirus treatment to the Biomedical Advanced Research and Development Authority (BARDA)”